3.115
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
19.78%
49.87
|
41.63 | 47.40 | 46.85 | 56.56 |
| Cost Of Revenue |
2.92%
37.02
|
35.98 | 39.63 | 39.12 | 37.17 |
| Gross Profit |
127.09%
12.84
|
5.655 | 7.768 | 7.725 | 19.39 |
|
|
53.44%
71.64
|
46.69 | 74.05 | 56.89 | 57.09 |
| Benefits Costs and Expenses |
30.07%
112.88
|
86.78 | 121.52 | 99.54 | 102.63 |
| Costs And Expenses |
53.44%
71.64
|
46.69 | 113.67 | 96.01 | 94.26 |
| Operating Income/Loss |
43.29%
-58.80
|
-41.03 | -66.28 | -49.16 | -37.70 |
| Income/Loss From Continuing Operations Before Tax |
39.56%
-63.01
|
-45.15 | -74.12 | -52.69 | -46.07 |
| Income Tax Expense/Benefit |
106.52%
0.006
|
-0.092 | -4.288 | 0.162 | -0.007 |
| Income/Loss From Continuing Operations After Tax |
39.86%
-63.02
|
-45.06 | -69.84 | -52.85 | -46.07 |
|
|
39.86%
-63.02
|
-45.06 | -69.84 | -52.85 | -46.07 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
40.17%
-27.33
|
-19.50 | -30.25 | -22.91 | -20.16 |
| Basic Average Shares |
99.83%
0.241
|
144.68 | 144.24 | 143.43 | 1.311 |
| Diluted Average Shares |
99.83%
0.241
|
144.68 | 144.24 | 143.43 | 1.311 |
| Basic Earnings Per Share |
33.33%
-0.24
|
-0.18 | -0.27 | -0.21 | -0.18 |
| Diluted Earnings Per Share |
33.33%
-0.24
|
-0.18 | -0.27 | -0.21 | -0.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):